UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="Yaz-0023mg-tablet-SE-AJ-MPD-BBDL"/>
<type value="collection"/>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"/>
<resource>
<MedicinalProductDefinition>
<id value="Yaz-0023mg-tablet-SE-AJ-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_Yaz-0023mg-tablet-SE-AJ-MPD"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Yaz-0023mg-tablet-SE-AJ-MPD</b></p><a name="Yaz-0023mg-tablet-SE-AJ-MPD"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-MPD"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-MPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100004813-00026267, <code>http://ema.europa.eu/fhir/eurdId</code>/10217</p><p><b>domain</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human use</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073665}">Film-coated tablet</span></p><p><b>indication</b>: </p><div><p>Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000095785}">drospirenone and ethinylestradiol</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Yaz 0,02 mg/3 mg Filmdragerad tablett</p><blockquote><p><b>part</b></p><p><b>part</b>: Yaz</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}">Invented Name Part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 0,02 mg/3 mg</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Filmdragerad tablett</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{urn:ietf:bcp:47 sv}">Swedish</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="SE-100004813-00026267"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/eurdId"/>
<value value="10217"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073665"/>
<display value="Film-coated tablet"/>
</coding>
</combinedPharmaceuticalDoseForm>
<indication
value="Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4)."/>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000093533"/>
<code value="100000095785"/>
<display value="drospirenone and ethinylestradiol"/>
</coding>
</classification>
<name>
<productName value="Yaz 0,02 mg/3 mg Filmdragerad tablett"/>
<part>
<part value="Yaz"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented Name Part"/>
</coding>
</type>
</part>
<part>
<part value="0,02 mg/3 mg"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="Filmdragerad tablett"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="sv"/>
<display value="Swedish"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/Yaz-0023mg-tablet-SE-AJ-RA"/>
<resource>
<RegulatedAuthorization>
<id value="Yaz-0023mg-tablet-SE-AJ-RA"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_Yaz-0023mg-tablet-SE-AJ-RA"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization Yaz-0023mg-tablet-SE-AJ-RA</b></p><a name="Yaz-0023mg-tablet-SE-AJ-RA"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-RA"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-RA-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/26267</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}">Valid</span></p><p><b>statusDate</b>: 2008-07-03</p><p><b>holder</b>: <a href="Organization-LOC-100016468.html">Organization Bayer AB</a></p><h3>Cases</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}">First Authorisation</span></td><td>2008-07-03</td></tr></table></div>
</text>
<identifier>
<system
value="http://ema.europa.eu/fhir/marketingAuthorizationNumber"/>
<value value="26267"/>
</identifier>
<subject>🔗
<reference
value="MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000060"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</region>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072049"/>
<code value="100000072099"/>
<display value="Valid"/>
</coding>
</status>
<statusDate value="2008-07-03"/>
<holder>🔗
<reference value="Organization/LOC-100016468"/>
</holder>
<case>
<type>
<coding>
<system
value="https://ema.europa.eu/fhir/authorisationDateType"/>
<code value="dateOfFirstAuthorisation"/>
<display value="First Authorisation"/>
</coding>
</type>
<dateDateTime value="2008-07-03"/>
</case>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Yaz-0023mg-tablet-SE-AJ-PPD"/>
<resource>
<PackagedProductDefinition>
<id value="Yaz-0023mg-tablet-SE-AJ-PPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_Yaz-0023mg-tablet-SE-AJ-PPD"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition Yaz-0023mg-tablet-SE-AJ-PPD</b></p><a name="Yaz-0023mg-tablet-SE-AJ-PPD"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-PPD"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-PPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></p><p><b>containedItemQuantity</b>: 84 tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Blister, 3 x 28 tabletter</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003208}">Plastic</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="84"/>
<unit value="tablet"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</containedItemQuantity>
<description value="Blister, 3 x 28 tabletter"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003208"/>
<display value="Plastic"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="3"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003200"/>
<display value="Aluminium"/>
</coding>
</material>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"/>
</reference>
</item>
<amount>
<value value="24"/>
<unit value="tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</amount>
</containedItem>
<containedItem>
<item>
<reference>
<reference
value="ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID02"/>
</reference>
</item>
<amount>
<value value="4"/>
<unit value="tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633~200000000014"/>
<code value="200000002152"/>
</amount>
</containedItem>
</packaging>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"/>
<resource>
<ManufacturedItemDefinition>
<id value="Yaz-0023mg-tablet-SE-AJ-MID01"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_Yaz-0023mg-tablet-SE-AJ-MID01"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition Yaz-0023mg-tablet-SE-AJ-MID01</b></p><a name="Yaz-0023mg-tablet-SE-AJ-MID01"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-MID01"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-MID01-en-US"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073665}">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002152}">tablet</span></p></div>
</text>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073665"/>
<display value="Film-coated tablet"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
<display value="tablet"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Yaz-0023mg-tablet-SE-AJ-ING01"/>
<resource>
<Ingredient>
<id value="Yaz-0023mg-tablet-SE-AJ-ING01"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Yaz-0023mg-tablet-SE-AJ-ING01"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Yaz-0023mg-tablet-SE-AJ-ING01</b></p><a name="Yaz-0023mg-tablet-SE-AJ-ING01"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-ING01"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-ING01-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></li><li><a href="ManufacturedItemDefinition-Yaz-0023mg-tablet-SE-AJ-MID01.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = tablet</a></li><li><a href="AdministrableProductDefinition-Yaz-0023mg-tablet-SE-AJ-APD01.html">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091531}">Ethinylestradiol betadex clathrate</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 173.17 microgram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091721}">Ethinylestradiol</span></td></tr></table><p><b>strength</b>: 20 microgram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Yaz-0023mg-tablet-SE-AJ-APD01"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091531"/>
<display value="Ethinylestradiol betadex clathrate"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="173.17"/>
<unit value="microgram(s)"/>
<system
value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110656"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system
value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</presentationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091721"/>
<display value="Ethinylestradiol"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="20"/>
<unit value="microgram(s)"/>
<system
value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110656"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system
value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Yaz-0023mg-tablet-SE-AJ-ING03"/>
<resource>
<Ingredient>
<id value="Yaz-0023mg-tablet-SE-AJ-ING03"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Yaz-0023mg-tablet-SE-AJ-ING03"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Yaz-0023mg-tablet-SE-AJ-ING03</b></p><a name="Yaz-0023mg-tablet-SE-AJ-ING03"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-ING03"> </a><a name="hcYaz-0023mg-tablet-SE-AJ-ING03-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Yaz-0023mg-tablet-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00026267,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></li><li><a href="ManufacturedItemDefinition-Yaz-0023mg-tablet-SE-AJ-MID01.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = tablet</a></li><li><a href="AdministrableProductDefinition-Yaz-0023mg-tablet-SE-AJ-APD01.html">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092375}">drospirenone</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 3 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092375}">drospirenone</span></td></tr></table><p><b>strength</b>: 3 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Yaz-0023mg-tablet-SE-AJ-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Yaz-0023mg-tablet-SE-AJ-MID01"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Yaz-0023mg-tablet-SE-AJ-APD01"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000092375"/>
<display value="drospirenone"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="3"/>
<unit value="milligram(s)"/>
<system
value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system
value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</presentationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000092375"/>
<display value="drospirenone"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="3"/>
<unit value="milligram(s)"/>
<system
value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system
value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100016468"/>
<resource>
<Organization>
<id value="LOC-100016468"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_LOC-100016468"> </a><p class="res-header-id"><b>Generated Narrative: Organization LOC-100016468</b></p><a name="LOC-100016468"> </a><a name="hcLOC-100016468"> </a><a name="hcLOC-100016468-en-US"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100016468</p><p><b>name</b>: Bayer AB</p></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/v1/locations"/>
<value value="LOC-100016468"/>
</identifier>
<name value="Bayer AB"/>
</Organization>
</resource>
</entry>
</Bundle>
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
